Alcon AG
Change company Symbol lookup
Select an option...
ALC Alcon AG
BEN Franklin Resources Inc
REGN Regeneron Pharmaceuticals Inc
PSNL Personalis Inc
CORR CorEnergy Infrastructure Trust Inc
SBRA Sabra Health Care REIT Inc
ZI ZoomInfo Technologies Inc
ATNI ATN International Inc
BAC Bank of America Corp
RACE Ferrari NV
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Based in Switzerland
Company profile

Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.

Price
Delayed
$78.58
Day's Change
0.67 (0.86%)
Bid
--
Ask
--
B/A Size
--
Day's High
79.46
Day's Low
78.35
Volume
(Average)

Today's volume of 611,651 shares is on pace to be in-line with ALC's 10-day average volume of 862,145 shares.

611,651

Ford stock lacks 'near-term upside,' RBC says on downgrade

11:46 am ET January 14, 2022 (MarketWatch)
Print

Analysts at RBC Capital Markets have downgraded their rating on Ford Motor Co. (F) stock to the equivalent of hold, saying in a note late Thursday that despite their belief that the auto maker's turnaround is "well underway" and Ford can continue to transition toward a future dominated by electric vehicles, autonomous vehicles, and software, "the upside looks a little more challenging so moving to sidelines for now." The analysts upped their price target on the stock to $26, from $21, representing an upside of around 4% over Friday's prices. Ford stock has taken off, up about 145% in the past 12 months, compared with gains of around 23% for the S&P 500 index in the same period. Ford is seen reporting fourth-quarter earnings later this month.

-Claudia Assis

	

(END) Dow Jones Newswires

January 14, 2022 11:46 ET (16:46 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.